Silence Therapeutics plc
SLN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479615
No open-market purchases or sales by Silence Therapeutics plc insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $236.2M in total; no superinvestor holds it.
Other share classesSLNCF
13F holders, Q1 2025
Institutional positions in Silence Therapeutics plc as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 59
- −5 vs. Q4 2024
- Shares held
- 21.9M
- −1.95M (−8.2%) vs. Q4 2024
- Total value
- $60.6M
- −$101.0M (−62.5%) vs. Q4 2024
- New holders
- 6
- 18 more added
- Sold out
- 11
- 25 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 72 | $236.2M |
| Q1 2026 | 56 | $102.1M |
| Q4 2025 | 58 | $106.1M |
| Q3 2025 | 54 | $96.4M |
| Q2 2025 | 55 | $108.0M |
| Q1 2025 | 59 | $60.6M |
| Q4 2024 | 65 | $168.2M |
| Q3 2024 | 69 | $493.1M |
| Q2 2024 | 71 | $502.1M |
| Q1 2024 | 64 | $588.0M |
| Q4 2023 | 34 | $343.9M |
| Q3 2023 | 28 | $187.6M |
| Q2 2023 | 29 | $101.8M |
| Q1 2023 | 29 | $110.2M |
| Q4 2022 | 27 | $275.7M |
| Q3 2022 | 29 | $183.4M |
| Q2 2022 | 25 | $116.4M |
| Q1 2022 | 26 | $218.3M |
| Q4 2021 | 22 | $246.6M |
| Q3 2021 | 7 | $39.4M |
| Q2 2021 | 6 | $56.4M |
| Q1 2021 | 6 | $55.9M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Silence Therapeutics plc; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 251 | $0 | 0.00% | +200+392.2% | Added |
| SBI Securities Co., Ltd. | 28 | $79 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 100 | $282 | 0.00% | 00.0% | Unchanged |
| GF Fund Management Co. Ltd. | 1,165 | $3.29K | 0.00% | +178+18.0% | Added |
| Parallel Advisors, LLC | 1,300 | $3.67K | 0.00% | +1,300 | New |
| Rhumbline Advisers | 1,875 | $5.28K | 0.00% | +1,034+122.9% | Added |
| Mirae Asset Global Investments Co., Ltd. | 1,573 | $5.41K | 0.00% | +7+0.4% | Added |
| Tower Research Capital LLC (TRC) | 2,367 | $6.67K | 0.00% | +1,735+274.5% | Added |
| Jones Financial Companies LLLP | 2,500 | $8.60K | 0.00% | +2,500 | New |
| GAMMA Investing LLC | 3,560 | $10.0K | 0.00% | −2,532−41.6% | Reduced |
| Royal Bank of Canada | 4,263 | $12.0K | 0.00% | +2,748+181.4% | Added |
| BNP Paribas Arbitrage, SA | 4,788 | $13.5K | 0.00% | +3,004+168.4% | Added |
| FNY Investment Advisers, LLC | 7,000 | $19.0K | 0.01% | −10,515−60.0% | Reduced |
| Barclays PLC | 6,854 | $19.3K | 0.00% | +728+11.9% | Added |
| Cubist Systematic Strategies, LLC | 7,364 | $20.8K | 0.00% | −98,956−93.1% | Reduced |
| China Universal Asset Management Co., Ltd. | 9,432 | $26.6K | 0.00% | −531−5.3% | Reduced |
| Acadian Asset Management LLC | 12,153 | $34.0K | 0.00% | −7,314−37.6% | Reduced |
| Point72 Asset Management, L.P. | 16,032 | $45.2K | 0.00% | −617,068−97.5% | Reduced |
| Rathbone Brothers plc | 18,421 | $51.9K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 18,643 | $52.6K | 0.01% | +643+3.6% | Added |
| Qube Research & Technologies Ltd | 18,913 | $53.3K | 0.00% | −35,833−65.5% | Reduced |
| Goldman Sachs Group Inc | 24,375 | $68.7K | 0.00% | −12,510−33.9% | Reduced |
| Virtus Investment Advisers, Inc. | 24,872 | $70.1K | 0.02% | +24,872 | New |
| Jump Financial, LLC | 26,351 | $74.3K | 0.00% | +26,351 | New |
| Geode Capital Management, LLC | 29,417 | $83.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 35,414 | $99.9K | 0.00% | +31,621+833.7% | Added |
| Shay Capital LLC | 47,728 | $134.6K | 0.04% | +47,728 | New |
| Two Sigma Advisers, LP | 49,200 | $138.7K | 0.00% | −49,600−50.2% | Reduced |
| Citigroup Inc | 61,071 | $172.2K | 0.00% | +569+0.9% | Added |
| Citadel Advisors LLC | 62,441 | $176.1K | 0.00% | −220,296−77.9% | Reduced |
| UBS Oconnor LLC | 62,639 | $176.6K | 0.00% | −66,351−51.4% | Reduced |
| Bank of America Corp | 64,886 | $183.0K | 0.00% | −434,180−87.0% | Reduced |
| Advisor Group Holdings, Inc. | 71,497 | $201.5K | 0.00% | +30,630+75.0% | Added |
| Two Sigma Investments, LP | 76,008 | $214.3K | 0.00% | −66,044−46.5% | Reduced |
| Woodline Partners LP | 134,492 | $379.3K | 0.00% | −364,240−73.0% | Reduced |
| Walleye Capital LLC | 136,150 | $383.9K | 0.00% | +99,753+274.1% | Added |
| Schonfeld Strategic Advisors LLC | 149,996 | $423.0K | 0.00% | +26,796+21.8% | Added |
| Bank of Montreal | 158,593 | $447.2K | 0.00% | +93,586+144.0% | Added |
| HSBC Holdings PLC | 172,834 | $499.5K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 180,435 | $508.8K | 0.00% | −31,072−14.7% | Reduced |
| M28 Capital Management LP | 185,100 | $522.0K | 0.72% | 00.0% | Unchanged |
| Marshall Wace, LLP | 228,418 | $644.1K | 0.00% | −260,471−53.3% | Reduced |
| Boothbay Fund Management, LLC | 250,012 | $705.0K | 0.03% | −101,515−28.9% | Reduced |
| SG Americas Securities, LLC | 308,289 | $869.0K | 0.00% | −9,339−2.9% | Reduced |
| UBS Group AG | 319,514 | $901.0K | 0.00% | −36,557−10.3% | Reduced |
| Millennium Management LLC | 396,862 | $1.12M | 0.00% | −76,690−16.2% | Reduced |
| Parkman Healthcare Partners LLC | 401,746 | $1.13M | 0.13% | −89,334−18.2% | Reduced |
| 5AM Venture Management, LLC | 476,200 | $1.34M | 0.51% | 00.0% | Unchanged |
| Saturn V Capital Management LLC | 732,463 | $2.07M | 1.04% | +337,439+85.4% | Added |
| Cantor Fitzgerald, L. P. | 773,845 | $2.18M | 0.08% | +234,119+43.4% | Added |
| Nextech Invest, Ltd. | 952,400 | $2.69M | 0.62% | +952,400 | New |
| Nantahala Capital Management, LLC | 1,042,427 | $2.94M | 0.24% | −7,249−0.7% | Reduced |
| Vivo Capital, LLC | 1,105,454 | $3.12M | 0.41% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 1,148,591 | $3.24M | 0.15% | 00.0% | Unchanged |
| Lombard Odier Asset Management (USA) Corp | 1,849,734 | $4.04M | 1.36% | −6,289−0.3% | Reduced |
| Morgan Stanley | 2,000,105 | $5.64M | 0.00% | +337,037+20.3% | Added |
| Redmile Group, LLC | 2,214,947 | $6.25M | 0.59% | −184,370−7.7% | Reduced |
| Siren, L.L.C. | 2,789,833 | $7.87M | 0.44% | −41,937−1.5% | Reduced |
| TCG Crossover Management, LLC | 3,033,560 | $8.55M | 1.17% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 0 | $0 | 0.00% | −640,000−100.0% | Sold out |
| Aquilo Capital Management, LLC | 0 | $0 | 0.00% | −367,214−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −63,663−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −24,123−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −21,217−100.0% | Sold out |
| Commonwealth of Pennsylvania Public School Empls Retrmt Sys | 0 | $0 | 0.00% | −19,467−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −16,360−100.0% | Sold out |
| Custom Index Systems, LLC | 0 | $0 | 0.00% | −11,861−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −10,772−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Nextech Invest AG | – | – | – | – | Not filed |